The circulating concentrations of IFN-γ and its regulated chemokines are increased and correlate with disease activity in a number of autoimmune diseases, such as alopecia areata, systemic lupus erythematosus, and Graves’ disease (28–33). Here, IFNG is linked to systemic lupus erythematosus.